Please login to the form below

Not currently logged in
Email:
Password:

company restructuring

This page shows the latest company restructuring news and features for those working in and with pharma, biotech and healthcare.

Boehringer starts to feel impact of Spiriva generics

Boehringer starts to feel impact of Spiriva generics

To that end, Boehringer is in the throes of a major restructuring of its businesses. ... Boehringer has also embarked on a restructuring of its human pharmaceuticals and innovation corporate board divisions, eliminating around 725 jobs in the US.

Latest news

  • Astellas sells dermatology unit to Leo for €675m Astellas sells dermatology unit to Leo for €675m

    Astellas sells dermatology unit to Leo for 675m. Continuesthe company's restructuring drive. ... Japan's Astellas has continued the restructuring of its business started in 2013 with the sale of its dermatology operations to Danish firm Leo Pharma.

  • Healthcare gets more independence in Google restructuring Healthcare gets more independence in Google restructuring

    Healthcare gets more independence in Google restructuring. New ‘ Alphabet’ company will put tech giant’ s health ventures centre-stage. ... the Internet arm, which generates most of the company's $60bn annual revenues.

  • GSK hints at more restructuring following income drop GSK hints at more restructuring following income drop

    GSK hints at more restructuring following income drop. Company experiences a tough 2014 with Advair competition and China bribery scandal. ... GlaxoSmithKline (GSK) has hinted at additional asset disposals and restructuring as it reported drops in both

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    This is a condition with few patient treatment options available, "said Shire's chief executive Flemming Ornskov, who has implemented a major restructuring drive at the company - including a concerted push ... Meanwhile, Shire also announced that chief

  • New York plant set to close as Novartis continues cutbacks New York plant set to close as Novartis continues cutbacks

    Last November, Novartis chief financial officer Harry Kirsch gave an update on the company's manufacturing restructuring programme, indicating that it has exited or divested 18 of more than 100 sites ... Since then, the company has also announced it

More from news
Approximately 1 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • Pharma deals during September 2014 Pharma deals during September 2014

    Company restructuring and portfolio rationalisation. Following restructuring by Pfizer, GSK, Novartis, Lilly and Merck &Co, Bayer has jumped on the portfolio rationalisation bandwagon with its decision to spin off as a ... separate listed company its

  • Sandra Rafferty: 'If I could change one thing…' Sandra Rafferty: 'If I could change one thing…'

    I met a friend recently who has been a sales rep for a number of years and she told me her company had been through a restructuring process to adopt the ... It is only when the perception of KAM is changed and a KAM approach is adopted fully across the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    She also most recently led the refocusing of the company’s oncology R&D strategy. ... Prior to this, as senior vice president of human resources and diversity, Mahony played in a role in restructuring the company into business units.

  • AZ names Dunoyer as CFO AZ names Dunoyer as CFO

    AZ names Dunoyer as CFO. He succeeds Simon Lowth as company restructure continues apace. ... Group. Dunoyer only joined AZ in June this year as executive VP, global portfolio and product strategy, to support the company's global restructuring programme.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics